More on the pathogenesis of thrombotic thrombocytopenic purpura. Comment on “Acquired thrombotic thrombocytopenic purpura without detectable anti-ADAMTS13 antibodies: a possible underlying autoimmune mechanism” and on “The different faces of thrombotic thrombocytopenic purpura”
Not available.
Saved in:
Main Author: | Flora Peyvandi |
---|---|
Format: | Article |
Language: | English |
Published: |
Ferrata Storti Foundation
2025-01-01
|
Series: | Haematologica |
Online Access: | https://haematologica.org/article/view/11926 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Thrombotic Thrombocytopenic Purpura Associated with Pneumococcal Sepsis
by: Jeffrey R Schriber, et al.
Published: (1993-01-01) -
Atypical Thrombotic Thrombocytopenic Purpura Presenting as Stroke
by: Pradeepthi Badugu, et al.
Published: (2019-01-01) -
Prophylactic use of recombinant ADAMTS-13 during pregnancy for congenital thrombotic thrombocytopenic purpura
by: Éloïse Colliou, et al.
Published: (2025-01-01) -
Approach to Management of Thrombotic Thrombocytopenic Purpura at University of Cincinnati
by: N. Abdel Karim, et al.
Published: (2013-01-01) -
De Novo Mutation of the ADAMTS13 Gene with Mesenteric Ischemia in an Infant with Congenital Thrombotic Thrombocytopenic Purpura
by: Ibrahim Alharbi, et al.
Published: (2021-01-01)